Letters to HCPs
Important information for Healthcare Professionals
Direct Healthcare Professional Communication on labelling exemption for Harvoni 45 mg/200 mg film-coated tablets due to supply disrupution in the UK. MHRA approval for use in UK of product packaged originally for the Irish market until 31 December 2020.
For Healthcare Professionals